BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.04 -0.07 (-1.60%)
As of: Oct 2, 2026 · 2:51 PM EDT

BriaCell Therapeutics (BCTX) Selling, General & Administrative (2021 - 2026)

Updated

BriaCell Therapeutics (BCTX) posted Selling, General & Administrative of $1.65 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 9.0% from $1.52 million a year earlier and up 11.9% from the prior quarter.

Analysis

BriaCell Therapeutics (BCTX) Selling, General & Administrative (2021 - 2026) Analysis & Trends

For the trailing twelve months through Apr 30, 2026, Selling, General & Administrative at BriaCell Therapeutics was $6.21 million, up 6.2% year-over-year; for FY2025 (ended Jul 31, 2025), it came in at $5.93 million, down 3.5% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 31.5% (FY2020 to FY2025).
  • In prior fiscal years, BriaCell Therapeutics' Selling, General & Administrative was $6.15 million in FY2024 (-22.5%), $7.94 million in FY2023 (+9.2%), $7.27 million in FY2022 (+46.7%) and $4.96 million in FY2021 (+227.7%).
  • The fiscal Q3 2026 figure stands as the highest quarterly Selling, General & Administrative since fiscal Q4 2023.
  • On a year-over-year basis, Selling, General & Administrative increased in three of the last eight quarters, with an average decline of 5.0%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q4 2022, with growth of 102.9%; the weakest was fiscal Q3 2022, with a decline of 49.6%.
  • According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $1.48 million (Q2 2026), $1.64 million (Q1 2026) and $1.44 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 BriaCell Therapeutics 31.03 Mn 30.38 Mn - 1.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 1.65 Mn
Jan 31, 2026 1.48 Mn
Oct 31, 2025 1.64 Mn
Jul 31, 2025 1.44 Mn
Apr 30, 2025 1.52 Mn
Jan 31, 2025 1.48 Mn
Oct 31, 2024 1.49 Mn
Jul 31, 2024 1.36 Mn
Apr 30, 2024 1.57 Mn
Jan 31, 2024 1.57 Mn
Oct 31, 2023 1.65 Mn
Jul 31, 2023 2.54 Mn
Apr 30, 2023 1.82 Mn
Jan 31, 2023 1.43 Mn
Oct 31, 2022 2.15 Mn
Jul 31, 2022 2.07 Mn
Apr 30, 2022 1.85 Mn
Jan 31, 2022 1.94 Mn
Oct 31, 2021 1.41 Mn
Jul 31, 2021 1.02 Mn
API Access

BriaCell Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BCTX&period=max&api_key=YOUR_API_KEY